Gelonghui October 30th | Hubei Guangji Pharmaceutical (000952.SZ) released the third quarter report for 2024, achieving revenue of 0.462 billion yuan in the first three quarters, a decrease of 11.54% year-on-year; net income attributable to shareholders of the listed company -0.159 billion yuan; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses -0.172 billion yuan; basic earnings per share -0.4498 yuan.
广济药业(000952.SZ)：前三季度净亏损1.59亿元
hubei guangji pharmaceutical (000952.SZ): a net loss of 0.159 billion yuan in the first three quarters.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated